Partners

If you are interested in exploring avenues for supporting this conference as a Media or Association Partner, please contact:

Eileen Tan
+65 6508 2462
Eileen.Tan@informa.com

Virtual Live Engagement Partner

Media Partners

Asia Research News is an international research communications company specializing in the Asia-Pacific region. Founded in 2004, we work with researchers and institutions to communicate their discoveries to the wider world. We launched Asia’s first research news platform, creating a framework for institutions to share their news directly with readers and journalists. Our experienced team offers a complete suite of communication services and training for research institutions looking to expand their international presence. Asia Research News is proud to support Asia’s research community and increase awareness of the region’s innovation. Find out more at http://asiaresearchnews.com

BioSpectrum Asia is the most influential source of information for life sciences industry and is uniquely positioned as a specialized B2B information platform in Asia Pacific region. The magazine provides comprehensive coverage and useful insights in the areas of pharmaceuticals, biotechnology, medical devices, research & development and policies.

Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has established long-term relationships with both multinational players and local firms, and continues to drive forward the health care industry.

GBI has offices in Shanghai, Beijing, and Washington D.C.

KONGPOSH Publications are one of the leading Pharma Publishers from INDIA.

The Pharma Review® is a bi-monthly article based journal. Contributions received from Eminent pharma personalities from India as well as other countries.

The journal has readership in many countries, provides media support to over 25 Pharma Expos and Conferences worldwide and has a large number of advertisers from India and overseas.

The journal is LISTED in Recommended Journals List of Pharmacy Council of INDIA for their approved Institutions. Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract & Listed Ulrich’s Database-USA, and Listed in Journals approved by UGC-INDIA.

On Line Link : www.kppub.com

Lingmed Ltd was founded in 2013 in Hong Kong, currently we have offices in Shanghai and Beijing. Lingmed promotes three leading intelligence databases for healthcare professionals in China to make better decisions

Lingmed’s core products are healthcare intelligence databases, it covers global innovative assets & China market intelligence. Lingmed’s Products and Services have been recognized by Fortune 500 multinational pharma and device companies as well as Chinese local big pharmacos

In addition, we provide partnering services to bridge European and Chinese pharmaceuticals with biotech companies, including valuation and market monitoring reports

Pharma China (www.pharmachinaonline.com) is the most trusted English media and business intelligence service covering the Chinese pharmaceutical / biopharmaceutical industry and market.

Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies.

  • Pharma China Journal Edition (monthly in PDF and Print)
  • Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases)
  • China Pharmaceutical Guide (the most comprehensive and authoritative reference for China’s healthcare sector)